Article Sidebar
Published:
Aug 7, 2026DOI:
10.4314/jdan.v17i1.2Keywords:
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Manuscripts are accepted for publication with the understanding that no substantial part has been, or will be published elsewhere. By submitting a manuscript, the authors agree that the copyright is transferred to the publisher if and when the articles, including reprints, photographic reproduction and translation are accepted for publication. Copyright owner is the Dietitians Association of Nigeria. An abstract at the beginning of an article may be reproduced without specific permission provided the original citation is provided. Statements made and opinions expressed in letters to the Editor, Editorials, Presidential address, book reviews and other special articles appearing in this journal are views of the author(s) and do not necessarily reflect the position of the Journal or the Association.
Main Article Content
Pilot study of avocado supplementation in an L-NAME rat model of hypertension and systemic injury
Abstract
Background: Endothelial dysfunction, hypertension, and multi-organ injury are major contributors to cardiovascular disease. Avocado (Persea americana) is rich in monounsaturated fatty acids, phytosterols, and antioxidants, but its protective effects against hypertension-induced systemic injury remain incompletely understood.
Objectives: To evaluate the effects of avocado pulp supplementation on L-NAME-induced hypertension and multi-organ injury in a rat model of nitric oxide synthase inhibition, and to provide proof-of-concept evidence supporting its potential role in cardiovascular and metabolic disease prevention.
Methods: Male Wistar rats (n = 4/group) were randomized into six groups: control, avocado, L-NAME, L-NAME+losartan+metoprolol succinate, L-NAME+avocado, and L-NAME+metoprolol succinate+avocado. Randomization used sealed opaque envelopes, and outcome assessment was blinded. Avocado pulp was incorporated into the diet at 80% (w/w). Outcomes included blood pressure, hematological parameters, liver enzymes, renal function, and systolic-diastolic blood pressure correlations. Data were analyzed using one-way ANOVA with Tukey's post hoc tests.
Results: L-NAME significantly increased systolic (+18 mmHg), diastolic (+20 mmHg), and mean arterial pressure (+17 mmHg) compared with controls (all p < 0.01). Avocado supplementation reduced these elevations by approximately 15–18 mmHg, restoring values near baseline. L-NAME also increased platelet counts (p = 0.031), elevated ALT (p = 0.044), and significantly increased urea (+25 mg/dL) and creatinine (+0.8 mg/dL; p < 0.01). Avocado supplementation attenuated these changes, reducing renal markers by 20–30% and maintaining liver enzyme levels near control values. Electrolytes remained unchanged. Correlation analysis showed pathological systolic-diastolic coupling in L-NAME rats (r = 0.78), which was abolished with avocado supplementation (r = 0.00).
Conclusion: This pilot proof-of-concept study demonstrates that avocado pulp supplementation attenuated L-NAME-induced hypertension and improved renal, hepatic, and hematological indices in rats. These findings provide biological plausibility for avocado as a dietary strategy to reduce cardiovascular and metabolic risk and support further investigation in larger, adequately powered preclinical and clinical studies.
